Marja van Meijer

1.1k total citations
18 papers, 919 citations indexed

About

Marja van Meijer is a scholar working on Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Marja van Meijer has authored 18 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Marja van Meijer's work include Protease and Inhibitor Mechanisms (8 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Marja van Meijer is often cited by papers focused on Protease and Inhibitor Mechanisms (8 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Marja van Meijer collaborates with scholars based in Netherlands, Canada and United States. Marja van Meijer's co-authors include Hans Pannekoek, Anton Jan van Zonneveld, John de Kruif, Jaap Goudsmit, Klaus T. Preissner, Menzo Havenga, Olga Ophorst, Anton J.G. Horrevoets, Mark Throsby and Wilfred E. Marissen and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Nature Biotechnology.

In The Last Decade

Marja van Meijer

17 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marja van Meijer Netherlands 13 453 290 232 224 223 18 919
Ahmad Faili France 18 843 1.9× 148 0.5× 178 0.8× 222 1.0× 181 0.8× 39 1.8k
C. Lagrou France 14 893 2.0× 71 0.2× 331 1.4× 176 0.8× 170 0.8× 19 1.3k
Chiung-Chi Kuo United States 16 561 1.2× 126 0.4× 171 0.7× 48 0.2× 179 0.8× 21 1.4k
J J O'Shea United States 15 268 0.6× 127 0.4× 81 0.3× 63 0.3× 342 1.5× 16 1.2k
Lori Jerome Canada 11 739 1.6× 248 0.9× 134 0.6× 143 0.6× 174 0.8× 18 979
Bernd Groner Germany 13 668 1.5× 47 0.2× 367 1.6× 130 0.6× 540 2.4× 19 1.3k
Gary M. Jones United States 16 421 0.9× 64 0.2× 119 0.5× 181 0.8× 164 0.7× 32 953
Vijaya L. Simhadri United States 12 699 1.5× 144 0.5× 171 0.7× 146 0.7× 230 1.0× 23 1.2k
Pamela Hamlyn United Kingdom 15 931 2.1× 131 0.5× 193 0.8× 61 0.3× 222 1.0× 20 1.5k
Gabriele Beck‐Engeser United States 19 465 1.0× 42 0.1× 130 0.6× 111 0.5× 151 0.7× 31 1.0k

Countries citing papers authored by Marja van Meijer

Since Specialization
Citations

This map shows the geographic impact of Marja van Meijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marja van Meijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marja van Meijer more than expected).

Fields of papers citing papers by Marja van Meijer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marja van Meijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marja van Meijer. The network helps show where Marja van Meijer may publish in the future.

Co-authorship network of co-authors of Marja van Meijer

This figure shows the co-authorship network connecting the top 25 collaborators of Marja van Meijer. A scholar is included among the top collaborators of Marja van Meijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marja van Meijer. Marja van Meijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Meijer, Marja van, et al.. (2025). Resting-state functional brain connectivity in female adolescents with first-onset anorexia nervosa. NeuroImage Clinical. 45. 103745–103745.
2.
Lee, David W., Dirk M. Zajonc, Rena R. Xian, et al.. (2012). Phage display generation of a novel human anti‐CD1A monoclonal antibody with potent cytolytic activity. British Journal of Haematology. 159(3). 299–310. 8 indexed citations
3.
Bicanic, Iva, Marja van Meijer, Gerben Sinnema, Elise M. van de Putte, & Miranda Olff. (2007). Neuroendocrine dysregulations in sexually abused children and adolescents: a systematic review. Progress in brain research. 167. 303–306. 4 indexed citations
4.
Ophorst, Olga, Stefan Kostense, Jaap Goudsmit, et al.. (2004). An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity. Vaccine. 22(23-24). 3035–3044. 63 indexed citations
5.
Bakker, Alexander B. H., Sonja van den Oudenrijn, Arjen Q. Bakker, et al.. (2004). C-Type Lectin-Like Molecule-1. Cancer Research. 64(22). 8443–8450. 196 indexed citations
6.
Havenga, Menzo, Angelique A. C. Lemckert, Olga Ophorst, et al.. (2002). Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of Disease. Journal of Virology. 76(9). 4612–4620. 155 indexed citations
7.
Huls, Gerwin, Ingmar Heijnen, Maria Emanuela Cuomo, et al.. (1999). A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments. Nature Biotechnology. 17(3). 276–281. 79 indexed citations
8.
Gårdsvoll, Henrik, Anton Jan van Zonneveld, Arne Holm, et al.. (1998). Selection of peptides that bind to plasminogen activator inhibitor 1 (PAI‐1) using random peptide phage‐display libraries. FEBS Letters. 431(2). 170–174. 17 indexed citations
9.
Stoop, A. Allart, Marja van Meijer, Anton J.G. Horrevoets, & Hans Pannekoek. (1997). Molecular Advances in Plasminogen Activator Inhibitor 1 Interaction with Thrombin and Tissue-Type Plasminogen Activator. Trends in Cardiovascular Medicine. 7(2). 47–51. 3 indexed citations
10.
Meijer, Marja van, et al.. (1997). The Composition of Complexes between Plasminogen Activator Inhibitor 1, Vitronectin and either Thrombin or Tissue-type Plasminogen Activator. Thrombosis and Haemostasis. 77(3). 516–521. 21 indexed citations
13.
Whelan, James, Marja van Meijer, Jialing Yu, et al.. (1995). Cloning of an Additional cDNA for the Alternative Oxidase in Tobacco. PLANT PHYSIOLOGY. 107(4). 1469–1470. 47 indexed citations
14.
Zonneveld, Anton Jan van, Birgit M.M. van den Berg, Marja van Meijer, & Hans Pannekoek. (1995). Identification of functional interaction sites on proteins using bacteriophage-displayed random epitope libraries. Gene. 167(1-2). 49–52. 40 indexed citations
15.
16.
Meijer, Marja van & Hans Pannekoek. (1995). Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: an update. Fibrinolysis and Proteolysis. 9(5). 263–276. 121 indexed citations
17.
Meijer, Marja van, Raymond Klein Gebbink, Klaus T. Preissner, & Hans Pannekoek. (1994). Determination of the vitronectin binding site on plasminogen activator inhibitor 1 (PAI‐1). FEBS Letters. 352(3). 342–346. 44 indexed citations
18.
Pannekoek, Hans, Marja van Meijer, Raymond R. Schleef, David J. Loskutoff, & Carlos F. Barbas. (1993). Functional display of human plasminogen-activator inhibitor 1 (PAI-1) on phages: novel perspectives for structure-function analysis by error-prone DNA synthesis. Gene. 128(1). 135–140. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026